Description
CoPlavix is indicated for the secondary prevention of atherothrombotic events in patients suffering from acute coronary syndrome: – Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q- wave myocardial infarction).
Additional information
| brand | Sanofi-aventis Pakistan |
|---|
